Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

IG Group FY profits jump as trading volumes, revenue per customer rise

(Sharecast News) - Online trading platform IG Group reported a jump in full-year profits and revenue on Thursday as trading volumes and revenue per customer rose. In the year ended 31 May, adjusted pre-tax profit rose 17% to £535.8m, with total revenue up 9% to £1.08bn, reflecting "supportive market conditions and good initial progress" implementing its strategy.

Net trading revenue ticked up 12% to £942.8m. IG said market conditions were more supportive across the year, resulting in increased trading volumes and higher revenue per customer.

Active customer numbers increased 137% to 820,000, driven by the acquisition of Freetrade, which added 457,300 active customers. On an organic basis, active customers increased 5% to 362,800.

IG said that Freetrade, which was bought earlier in the year, performed strongly in FY25, with total revenue up 22% to £29.1m and contributing £4.8m to group revenue in the two months since completion.

Chief executive Breon Corcoran said: "In the first year implementing our strategy, we have made good initial progress delivering on our priorities of improving our product, embedding a high-performance culture and enhancing efficiency. I am pleased that we are getting closer to our customers and accelerating product velocity which is translating into stronger customer acquisition.

"During the year, we also reshaped our senior leadership team with new managing directors for three of our five commercial divisions. These leaders have already had a significant impact, enhancing performance and accelerating change by strengthening our high-performance culture.

"Looking forward, we are confident of meeting market expectations for total revenue and cash EPS in FY26. Beyond FY26, we expect total revenue to compound in a mid-to-high single-digit percentage range per annum on an organic basis, accelerating within this range over time, with cost discipline."

At 1010 BST, the shares were up 5.7% at 1,119.47p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.